Banco BTG Pactual SA, Latin America’s largest independent investment bank, agreed to buy HSBC Holdings Plc’s operations in ...

A U.S. unit of British drug company BTG Plc pleaded guilty on Monday to improperly marketing its embolic device LC Bead, and will pay about $36 million to resolve its criminal and civil liability ...

Boston Scientific Corp. BSX 0.67% has agreed to buy British health-care firm BTG PLC for £3.3 billion ($4.24 billion), bolstering its presence in the growing field of interventional medicine ...

To bolster its offerings in interventional medicine, Boston Scientific agreed to purchase British device and pharma firm BTG PLC. for $4.24 billion in cash, according to The Wall Street Journal.

BTG plc (LSE:BTG) trades with a trailing P/E of 79.1x, which is higher than the industry average of 38.4x. Although some investors may jump to the conclusion that you shouldRead More ...

BTG plc (LSE: BTG), a global specialist healthcare company, and the Society of Interventional Oncology (SIO), an international organisation working to nurture and support interventional oncology ...

BTG plc (LSE: BTG), the global specialist healthcare company, today announces it has acquired Novate Medical Ltd. (“Novate”), a medical device company ...

Boston Scientific Corp. BSX said Tuesday that it has agreed to a takeover bid for U.K. specialty health-care company BTG PLC (BTG.LN) in a deal worth 3.3 billion pounds ($4.23 billion). The ...

British healthcare company BTG Plc <BTG.L> has acquired Irish medical device maker Novate Medical, adding to its portfolio a vascular device for managing blood clots.

Shares of BTG PLC (BTG.LN) fell in early trade Friday after the health-care company said that a U.S. Food & Drug Administration panel has voted against the approval of its Elevair Endobronchial ...

Galil Medical Inc., a developer of cryoablation products for the treatment of kidney and other cancers, has agreed to be acquired by specialist health-care company BTG PLC. BTG will pay $84.5 ...

BTG Plc, a London-based specialty pharmaceutical company, won U.S. approval for its drug to combat the toxic effects of a cancer treatment. The Food and Drug Administration cleared the medicine to ...